Ownership history in UBS Group AG · 25 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in HOTH THERAPEUTICS INC (HOTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 58,341 | -36,324 | -38.4% | 0.00% | $58K | $0.99 |
| 2025 Q3 | ADDED | 94,665 | +52,425 | +124.1% | 0.00% | $153K | $1.62 |
| 2025 Q2 | REDUCED | 42,240 | -16,518 | -28.1% | 0.00% | $49K | $1.17 |
| 2025 Q1 | ADDED | 58,758 | +27,765 | +89.6% | 0.00% | $59K | $1.00 |
| 2024 Q4 | REDUCED | 30,993 | -25,471 | -45.1% | 0.00% | $23K | $0.75 |
| 2024 Q3 | ADDED | 56,464 | +13,109 | +30.2% | 0.00% | $50K | $0.88 |
| 2024 Q2 | ADDED | 43,355 | +41,205 | +1916.5% | 0.00% | $39K | $0.91 |
| 2024 Q1 | REDUCED | 2,150 | -6,297 | -74.5% | 0.00% | $3K | $1.52 |
| 2023 Q4 | ADDED | 8,447 | +4,297 | +103.5% | 0.00% | $12K | $1.44 |
| 2023 Q3 | REDUCED | 4,150 | -144 | -3.4% | 0.00% | $6K | $1.52 |
As of 2025 Q4 — sorted by position size